{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:30Z","timestamp":1786120350442,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/inf.0b013e31824b972b","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T07:15:32Z","timestamp":1328598932000},"page":"392-399","source":"Crossref","is-referenced-by-count":24,"title":["13-valent Pneumococcal Conjugate Vaccine Given With Meningococcal C\u2013Tetanus Toxoid Conjugate and Other Routine Pediatric Vaccinations"],"prefix":"10.1097","volume":"31","author":[{"given":"Federico","family":"Martin\u00f3n-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gimenez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Gurtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Bernaola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Diez-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohinder","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A.","family":"Sarkozy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio A.","family":"Emini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-15-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Active Bacterial Core SurveillanceEmerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine..","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"R4-15-20210202","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10096-008-0693-1","article-title":"Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine..","volume":"28","author":"Perez-Trallero","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R6-15-20210202","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1016\/j.vaccine.2010.04.008","article-title":"006 study group. Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany.","volume":"28","author":"Kieninger","year":"2010","journal-title":"Vaccine"},{"key":"R7-15-20210202","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1542\/peds.2009-3027","article-title":"004 Study Group. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers.","volume":"126","author":"Yeh","year":"2010","journal-title":"Pediatrics"},{"key":"R8-15-20210202","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R9-15-20210202","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.anpedi.2008.10.001","article-title":"Asociacion Espanola de Pediatria. Vaccination schedule of the Spanish association of pediatrics: recommendations 2009.","volume":"70","author":"Bernaola Iturbe","year":"2009","journal-title":"An Pediatr (Barc)"},{"key":"R10-15-20210202","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R11-15-20210202","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1128\/CDLI.11.6.1064-1069.2004","article-title":"Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f).","volume":"11","author":"Quataert","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"R12-15-20210202","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"R13-15-20210202","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection-serum bactericidal antibody activity.","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"R14-15-20210202","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/00365548609032331","article-title":"Serological immunity to diphtheria in Sweden in 1978 and 1984.","volume":"18","author":"Christenson","year":"1986","journal-title":"Scand J Infect Dis"},{"key":"R15-15-20210202","first-page":"683","article-title":"Immunization against neonatal tetanus in New Guinea. Antitoxin response of pregnant women to adjuvant and plain toxoids.","volume":"32","author":"MacLennan","year":"1965","journal-title":"Bull World Health Organ"},{"key":"R18-15-20210202","first-page":"e167","article-title":"Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers receiving routine vaccinations in Spain.","volume":"28","author":"Diez-Domingo","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R19-15-20210202","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1016\/j.vaccine.2011.06.026","article-title":"501 and 006 study groups. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine.","volume":"29","author":"Gimenez-Sanchez","year":"2011","journal-title":"Vaccine"},{"key":"R20-15-20210202","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/INF.0b013e3181faa6be","article-title":"Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial.","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R21-15-20210202","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1016\/j.vaccine.2010.09.047","article-title":"Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines.","volume":"28","author":"Wysocki","year":"2010","journal-title":"Vaccine"},{"key":"R22-15-20210202","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1016\/j.vaccine.2006.03.032","article-title":"Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPVHib combination vaccine in healthy infants.","volume":"24","author":"Knuf","year":"2006","journal-title":"Vaccine"},{"key":"R23-15-20210202","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.vaccine.2007.11.096","article-title":"Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.","volume":"26","author":"Olivier","year":"2008","journal-title":"Vaccine"},{"key":"R25-15-20210202","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1001\/jama.293.14.1751","article-title":"Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial.","volume":"293","author":"Buttery","year":"2005","journal-title":"JAMA"},{"key":"R27-15-20210202","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/IAI.73.1.369-377.2005","article-title":"Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.","volume":"73","author":"Ekstrom","year":"2005","journal-title":"Infect Immun"},{"key":"R28-15-20210202","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/INF.0b013e3181d99345","article-title":"Immunogenicity of alternative regimens of the conjugated 7-valent pneumococcal vaccine: a randomized controlled trial.","volume":"29","author":"Givon-Lavi","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R29-15-20210202","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1542\/peds.2009-1405","article-title":"PCV13 Infant Study Group. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.","volume":"125","author":"Bryant","year":"2010","journal-title":"Pediatrics"},{"key":"R33-15-20210202","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/j.vaccine.2008.03.087","article-title":"Effectiveness of a 21 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.","volume":"26","author":"Vestrheim","year":"2008","journal-title":"Vaccine"},{"key":"R34-15-20210202","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/INF.0b013e3181cffa2a","article-title":"Effectiveness of pneumococcal conjugate vaccine using a 21 infant schedule in Quebec, Canada.","volume":"29","author":"Deceuninck","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R35-15-20210202","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.vaccine.2009.01.052","article-title":"Collaborative Group for Pneumococcal Vaccination in Liguria. Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy.","volume":"27","author":"Durando","year":"2009","journal-title":"Vaccine"},{"key":"R36-15-20210202","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.","volume":"29","author":"Miller","year":"2011","journal-title":"Vaccine"},{"key":"R37-15-20210202","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/AAC.01594-09","article-title":"Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine.","volume":"54","author":"Fenoll","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-15-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.","volume":"46","author":"Munoz-Almagro","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e31824b972b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:32:57Z","timestamp":1786048377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201204000-00015"}},"subtitle":["Immunogenicity and Safety"],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31824b972b","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}